Plural
Carina N. is a seasoned venture capitalist and entrepreneur currently serving as a Partner at Plural, an early-stage investment fund focused on impactful technology-driven ventures. Carina co-founded HelixNano, an AI-driven biotech company specializing in next-generation mRNA therapies, and has held several significant board positions, including Board Trustee at The Alan Turing Institute and Board Member roles at Robin AI, Sano Genetics, Omnipresent, Phasecraft, MediShout, and Auquan. Additionally, Carina was a General Partner at Episode 1 Ventures until 2022. Carina's educational background includes degrees from the University of Oxford and Y Combinator.
This person is not in any teams
This person is not in any offices
Plural
Plural is an early-stage investment fund that backs the most ambitious founders on a mission to change the world through technology. It launched in June 2022 with the aim to give serious founders in Europe investors with company-building experience to match their ambition. Plural’s mission is to have GDP-level impact on Europe, address systemic risks and reduce the opportunity gap worldwide through the companies it backs.